Skip to main content
SpringerLink
Log in

Research Pipeline I: Topical Therapies

  • Chapter
  • First Online:
Book cover Advances in Psoriasis

  • 1204 Accesses

Abstract

Psoriasis is a common chronic inflammatory skin disease affected by both genetics and immune factors. This devastating disease has a huge impact on the quality of life of affected individuals and a pronounced economic burden on the society. Recent understanding of the immunopathogenesis of psoriasis has led to significant progress in its treatment. Many disease-related factors affect the choice of therapy. Mild psoriasis can generally be managed with topical medications, while moderate-to-severe psoriasis is conventionally treated with more aggressive systemic therapies. The ideal treatment should be cost-effective, provide long-term remission and exhibit few side effects. This chapter highlights topical therapies currently under development for psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Foundation/USA NP. http://psoriasis.org/research/drugs-in-development/pipeline. Accessed 27 Sept 2011.

  2. Krueger G, Ellis CN. Psoriasis-recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol. 2005;53(1 Suppl 1):S94–100.

    Article  PubMed  Google Scholar 

  3. Guenther LC, Ortonne JP. Pathophysiology of psoriasis: science behind therapy. J Cutan Med Surg. 2002;6(3 Suppl):2–7.

    Article  PubMed  Google Scholar 

  4. Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol. 2003;49(2 Suppl):S44–50.

    Article  PubMed  Google Scholar 

  5. Lebwohl M. Psoriasis. Lancet. 2003;361(9364):1197–204.

    Article  PubMed  Google Scholar 

  6. Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep. 2007;9(6):461–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Owaki T, Asakawa M, Morishima N, et al. A role for IL-27 in early regulation of Th1 differentiation. J Immunol. 2005;175(4):2191–200.

    Article  CAS  PubMed  Google Scholar 

  8. Shibata S, Tada Y, Kanda N, et al. Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol. 2010;130(4):1034–9.

    Article  CAS  PubMed  Google Scholar 

  9. Baeumer W, Hoppmann J, Rundfeldt C, Kietzmann M. Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets. 2007;6:17–26.

    Article  CAS  Google Scholar 

  10. Nazarian R, Weinberg JM. AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr Opin Investig Drugs. 2009;10(11):1236–42.

    CAS  PubMed  Google Scholar 

  11. Freund Y, Alley M, Kimura R, et al. In vitro activity and mechanism of action of AN2728, a novel oxaborole in development for treatment of psoriasis. J Invest Dermatol. 2008;128 Suppl 1:Abs 89.

    Google Scholar 

  12. Clinicaltrials.gov. http://clinicaltrials.gov/ct2/show/NCT01029405?term=an2728&rank=1. Accessed 27 Sept 2011.

  13. Beutner K, Gassmueller I, Marti D, Lathrop A. AN2728, a novel oxaborole in development for treatment of psoriasis, demonstrates significant activity in a micro plaque study. J Invest Dermatol. 2008;128 Suppl 1:Abs 367.

    Google Scholar 

  14. Biomas-pharma company World Wide Website. http://biomas-pharma.com/Page.asp?PiD=0.2&id=13. Accessed 27 Sept 2011.

  15. Incyte company World Wide Website. http://incyte.com/drugs_product_pipeline.html. Accessed 27 Sept 2011.

  16. Nickoloff BJ. Cracking the cytokine code in psoriasis. Nat Med. 2007;13(3):242–4.

    Article  CAS  PubMed  Google Scholar 

  17. Duffin KC, Luchi M, Fidelus-Gort R, et al. JAK 1/Jak 2 inhibition: a novel mechanism in the treatment of chronic plaque psoriasis. Society for Investigative Dermatology Meeting, Atlanta, 2010.

    Google Scholar 

  18. Dermipsor company World Wide Website. http://dermi-psor.com. Accessed 27 Sept 2011.

  19. Mediquest Therapeutics company World Wide Website. http://mqti.com/technology.cfm. Accessed 27 Sept 2011.

  20. Clinicaltrials.gov. http://clinicaltrials.gov/ct2/show/NCT00666354. Accessed 27 Sept 2011.

  21. Ortonne JP, Noerrelund KL, Papp K, et al. Comparison of two different dose combinations of calcipotriol/hydrocortisone ointment used once daily for the treatment of psoriasis vulgaris on the face and body. Eur J Dermatol. 2010;20(5):585–9.

    CAS  PubMed  Google Scholar 

  22. Welichem Biotech Inc. company World Wide Website. http://welichem.com/wbi_1001.php. Accessed 27 Sept 2011.

  23. Creabilis Therapeutics company World Wide Website. http://www.creabilis-sa.com/projects.php?id=2. Accessed 27 Sept 2011.

  24. Clinicaltrials.gov. http://clinicaltrials.gov/show/NCT00995969. Accessed 27 Sept 2011.

  25. Maruho C, Ltd., Chugai Pharmaceutical C, Ltd. Approval of a new indication for Oxarol® ointment/lotion (nonproprietary name: maxacalcitol), psoriasis vulgaris treatment topical products containing active vitamin D3, for extended treatment of palmoplantar pustulosis. http://maruho.co.jp/english/pdf/2008/0811oxarol_pr_eng.pdf. Accessed 27 Sept 2011.

  26. Clinicaltrials.gov. http://clinicaltrials.gov/ct2/show/NCT01360944. Accessed 27 Sept 2011.

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA

    Bassel Mahmoud MD, PhD & Linda Stein Gold MD

Authors
  1. Bassel Mahmoud MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Linda Stein Gold MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Linda Stein Gold MD .

Editor information

Editors and Affiliations

  1. St. Luke's -Roosevelt Hospital Center, New York, New York, USA

    Jeffrey M. Weinberg

  2. Department of Dermatology, Icahn School of Medicine, New York, New York, USA

    Mark Lebwohl

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Mahmoud, B., Gold, L.S. (2014). Research Pipeline I: Topical Therapies. In: Weinberg, J., Lebwohl, M. (eds) Advances in Psoriasis. Springer, London. https://doi.org/10.1007/978-1-4471-4432-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4432-8_17

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4431-1

  • Online ISBN: 978-1-4471-4432-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation